Last reviewed · How we verify
NCT03870867: FALLS
The Emergency Department Falls Study
trial testing No intervention in Fall in 1,753 participants. Completed in 31 December 2017.
31 December 2017
Quick facts
| Lead sponsor | Hamilton Health Sciences Corporation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,753 |
| Start date | 14 December 2015 |
| Primary completion | 31 December 2017 |
| Estimated completion | 31 December 2017 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- No intervention
Conditions studied
- Fall — all drugs for Fall →
- Head Injury Trauma — all drugs for Head Injury Trauma →
- Intracranial Hemorrhages — all drugs for Intracranial Hemorrhages →
Sponsor
Hamilton Health Sciences Corporation — full company profile →
Who can join
65 and older, any sex, with Fall or Head Injury Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a pilot study to evaluate clinical predictors of intracranial bleeding in elderly patients who present to the emergency department (ED) after a fall. The aim is to assess feasibility and rate of patient recruitment, patient follow up, and to establish a point estimate for the incidence of intracranial bleeding in the investigator's population. Currently there are no guidelines for ED physicians to assess the pretest probability of intracranial bleed in these patients, and no safe way to exclude a bleed without CT.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Reliability of patient-reported outcome measures: Hemorrhage, anticoagulant, antiplatelet medication use.
Selvanayagam N, Mowbray F, Clayton N, Soomro A, et al · · 2021 · cited 2× · PMID 34027288 · DOI 10.1002/rth2.12501
Verify or expand the search:
- PubMed search for NCT03870867
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Fall
Currently open trials in the same condition.
- NCT07433153 — Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults · NA · recruiting
- NCT07458958 — Guangzhou Community Elderly Fall Prevention Appropriate Technology Promotion Project · NA · recruiting
- NCT07216846 — The Geriatric Emergency Department Pharmacologic Harm Prevention Project · NA · recruiting
- NCT07350408 — Mapping Post-falls Organisational Processes in Care Homes · recruiting
- NCT06577662 — Effects of an Individual and Family Self-Management of Fall Prevention Program on Balance Ability and Fall-related Self- · NA · active not recruiting
Other Hamilton Health Sciences Corporation trials
Trials by the same sponsor.
- NCT06567808 — Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial · Phase 4 · not yet recruiting
- NCT07118696 — Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease · Phase 3 · not yet recruiting
- NCT07027436 — Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Su · Phase 3 · not yet recruiting
- NCT06908694 — Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy · Phase 4 · recruiting
- NCT06836024 — A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03870867 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hamilton Health Sciences Corporation
- Last refreshed: 12 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03870867.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing